Emma Court, Bloomberg

Emma Court


New York, NY, United States

Contact Emma

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Bloomberg
  • Business Insider
  • Business Insider SG
  • Moneyish
  • The Atlantic
  • Cashay
  • Wall Street Journal
  • New York Post

Recent articles by Emma:

Obesity Drug Helps Patients Lose About 20% of Weight, Lilly Says

Eli Lilly & Co.’s obesity drug tirzepatide helped patients on the highest dose shed about 21% of their body weight, or roughly 50 pounds, in a late-stage clinical trial, the company said early Thursday. → Read More

Where Is the Operation Warp Speed for Covid Testing?

An all-out effort paid off in developing vaccines, but America continues to lurch from one wave of the virus to another without a meaningful plan for ongoing surveillance. → Read More

Merck’s Covid Pill Must First Overcome Anti-Vax Misinformation

Unproven claims on social media that ivermectin is effective against coronavirus could trim demand for the drugmaker’s new treatment. → Read More

Covid Pills May Save Lives, But They Won’t End the Pandemic

While new treatments from Pfizer and Merck have the potential to keep people out of the hospital, vaccines are still the best weapon for fighting Covid. → Read More

Harvard Immunologist Champions At-Home Covid Tests to Beat the Pandemic

Michael Mina says the U.S. should be following in the footsteps of Germany and the U.K. in making low-cost, rapid tests readily available to consumers. → Read More

Biden Plans $1 Billion Push to Boost Rapid Covid-19 Testing

The Biden administration will announce a $1 billion purchase of rapid at-home Covid-19 tests on Wednesday, an additional investment geared at expanding the availability of such products in the coming months, a White House official said. → Read More

Three Doses Could Become Standard Covid Regimen, Fauci Says

Three doses of Covid-19 vaccine may become the standard regimen for most people, White House chief medical adviser Anthony Fauci said Thursday at a briefing. → Read More

New Obesity Drug Must Convince Insurers That It’s Worth the Cost

Novo Nordisk’s Wegovy could be a really big hit—if it’s covered. → Read More

Why Some Vaccinated People Still Get Covid

In this week's edition of the Covid Q&A, we look at when a person who has been fully vaccinated still develops Covid-19, or what’s known among epidemiologists as a “breakthrough” infection. In hopes of making this very confusing time just a little less so, each week Bloomberg Prognosis is picking one question sent in by readers and putting it to an expert in the field. This week's question is: → Read More

What the Fresh, New, Latest U.S. Rules on Masks Mean

U.S. authorities have been all over the map when it comes to whether ordinary people should wear masks in the era of the coronavirus. At the start of the pandemic in early 2020, the Centers for Disease Control and Prevention discouraged it in most circumstances, in part to preserve supplies for health workers, before changing its position only in April of that year. One of President Joe Biden’s… → Read More

CDC Says Fully Vaccinated People Can Go Without Masks

Fully vaccinated Americans can do away with wearing masks, the head of the U.S. Centers for Disease Control and Prevention said, the most significant shift in federal guidelines since the start of the pandemic. → Read More

Herd Immunity Is Humanity’s Great Hope, and It’s Proving Elusive

Variants have become so significant that researchers now say ending the pandemic will be gradual, with bumps along the way. → Read More

U.S. Created a Data Disaster With Its Uneven Covid Response

More than a month into a resurgence of the novel coronavirus that has besieged Sun Belt states, flooded hospitals and strained public-health infrastructure, the U.S. still lacks a complete picture of the on-the-ground reality. → Read More

Drugmakers Have Even Less Reason to Fear Price Reform Now

With people hoping for a coronavirus vaccine, Congress has less leverage to rein in the industry. → Read More

Drugmakers Have Even Less Reason to Fear Price Reform Now

With people hoping for a coronavirus vaccine, Congress has less leverage to rein in the industry. → Read More

WeWork board members are talking about ousting CEO Adam Neumann amid IPO turmoil

WeWork CEO Adam Neumann founded the company and built it to what it is today. But his leadership has also come under fierce criticism. → Read More

Opioid-maker Purdue Pharma’s bankruptcy filing shines a rare light on a system criticized for raising US drug prices

Purdue Pharma owes millions to pharmacy chain CVS, health insurer UnitedHealth, and state health departments. → Read More

The CEO of a startup that sells Viagra online just accused a rival of ripping off his company's website

The design and much of the text are the same, Ro CEO Zachariah Reitano said in a Medium post on Monday. And yes, he took screenshots. → Read More

Poop-testing startup uBiome was once valued at $600 million by Silicon Valley’s top VCs. It just filed for bankruptcy.

The poop-testing firm said it hopes to entice an investor to purchase it for its scientific knowledge. It also aims to sell its sole remaining product at CVS. → Read More

Buzzy microbiome startup uBiome just filed for bankruptcy

uBiome filed for bankruptcy on Wednesday. The company took on an $8 million loan that will help it to stay open while it searches for a buyer. → Read More